MedTrace Logo

Muscle Assessment Through Ultrasound in the Evaluation of Acute Sarcopenia

NCT03740061 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-04-28

No results posted yet for this study

Summary

Traditionally, muscle mass - a part of the concept of sarcopenia - is measured by computed tomography (CT) or dual-energy X-ray absorptiometry (DEXA) scan. These devices are not always easily available in clinical practice and cannot be used bedside. An innovation in sarcopenia is the assessment of muscle mass and quality with ultrasound. Because this device is much more available and applicable in all patients, diagnosis of acute sarcopenia would be much easier with ultrasound. Moreover, if other factors that contribute to accelerated decline in muscle mass and function can be determinated, the sensiblisation and early screening for acute sarcopenia in those individuals can hopefully prevent them from declining.

Conditions

Interventions

DIAGNOSTIC_TEST

Ultrasonographic assessment of muscle

Ultrasonographic assessment of quadriceps muscle

Sponsors & Collaborators

  • Hospital Universitario Ramon y Cajal

    collaborator OTHER

  • Universitaire Ziekenhuizen KU Leuven

    collaborator OTHER

  • Medical University of Bialystok

    collaborator OTHER

  • Catholic University of the Sacred Heart

    collaborator OTHER

  • Universitat Autonoma de Barcelona

    collaborator OTHER

  • Jagiellonian University

    collaborator OTHER

  • Universitat Pompeu Fabra

    collaborator OTHER

  • Istanbul University

    collaborator OTHER

  • University of Oldenburg

    collaborator OTHER

  • Universiteit Antwerpen

    lead OTHER

Principal Investigators

  • Stany Perkisas, MD · Universiteit Antwerpen

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2022-03-01
Completion
2022-04-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03740061 on ClinicalTrials.gov